Fosfomycin Supplier-Buyer Network — Trade Flow Analysis

Name: Fosfomycin Supplier-Buyer Trade Network Dataset — 73+ Indian Exporters, 8+ Importers, 46+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Fosfomycin supplier network, Fosfomycin buyers, pharmaceutical export India, Fosfomycin trade data

TransData Nexus

Fosfomycin

India Pharmaceutical Trade Intelligence

$12.9M73 Suppliers46 CountriesHS 30049099

ExportsIndia → UNITED STATES76.9%India → GERMANY9.3%

ImportsSWITZERLAND → India$74.5M ITALY → India$539.8K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Who Supplies Fosfomycin? Top Manufacturers & Buyers 2026 — CIPLA LIMITED Leads | TransData Nexus | TransData Nexus

1CIPLA LIMITED

CIPLA LIMITED is the first-largest Fosfomycin exporter from India, with a market share of 50.9% and a total export value of $6.6M across 120 shipments. Their average shipment value of $54.7K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 3 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 77.5% of this supplier's tracked business. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $5.1M across 93 shipments (77.5% of this supplier's total exports)

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.5M across 27 shipments (22.4% of this supplier's total exports)

• KIND ATTN; MR. JAUME — $3.6K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $54.7K is 109% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

2SWISS PARENTERALS LIMITED

SWISS PARENTERALS LIMITED is the second-largest Fosfomycin exporter from India, with a market share of 8.9% and a total export value of $1.2M across 27 shipments. Their average shipment value of $42.7K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

SWISS PARENTERALS LIMITED serves 4 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 84.7% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF — $976.1K across 23 shipments (84.7% of this supplier's total exports)

• TO THE ORDER — $140.6K across 3 shipments (12.2% of this supplier's total exports)

• TO THE ORDER OF — $19.5K across 0 shipments (1.7% of this supplier's total exports)

• TO THE ORDER OF — $16.5K across 0 shipments (1.4% of this supplier's total exports)

Key Insight: SWISS PARENTERALS LIMITED's per-shipment value of $42.7K is 63% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

3AMNEAL PHARMACEUTICALS PRIVATE LIMITED

AMNEAL PHARMACEUTICALS PRIVATE LIMITED is the third-largest Fosfomycin exporter from India, with a market share of 1.7% and a total export value of $215.4K across 3 shipments. Their average shipment value of $71.8K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

AMNEAL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. AMNEAL PHARMACEUTICALS, LLC (KY) is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• AMNEAL PHARMACEUTICALS, LLC (KY) — $215.4K across 3 shipments (100.0% of this supplier's total exports)

Key Insight: AMNEAL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $71.8K is 174% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

4AVANTIKA MEDEX PRIVATE LIMITED

AVANTIKA MEDEX PRIVATE LIMITED is the fourth-largest Fosfomycin exporter from India, with a market share of 1.3% and a total export value of $172.6K across 6 shipments. Their average shipment value of $28.8K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

AVANTIKA MEDEX PRIVATE LIMITED serves 1 named buyer in our database. MCHZH KONARK PHARM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• MCHZH KONARK PHARM — $172.6K across 6 shipments (100.0% of this supplier's total exports)

Key Insight: AVANTIKA MEDEX PRIVATE LIMITED's per-shipment value of $28.8K is 10% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

5SRS PHARMACEUTICALS PRIVATE LIMITED

SRS PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Fosfomycin exporter from India, with a market share of 1.0% and a total export value of $131.3K across 9 shipments. Their average shipment value of $14.6K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.

SRS PHARMACEUTICALS PRIVATE LIMITED serves 3 named buyers in our database. AVIV FARMACEUTICA S.ACALZADA is the dominant customer, accounting for 83.0% of this supplier's tracked business. Top customers include:

• AVIV FARMACEUTICA S.ACALZADA — $109.1K across 7 shipments (83.0% of this supplier's total exports)

• AV.12 DE OCTUBRE N26 — $21.9K across 2 shipments (16.7% of this supplier's total exports)

• NORTH LIFE PHARMA EC — $340 across 0 shipments (0.3% of this supplier's total exports)

Key Insight: SRS PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $14.6K, indicating a broad distribution network with many smaller, regular orders.

6INDASI LIFESCIENCE PRIVATE LIMITED

INDASI LIFESCIENCE PRIVATE LIMITED is the fifth-largest Fosfomycin exporter from India, with a market share of 1.0% and a total export value of $122.7K across 6 shipments. Their average shipment value of $20.5K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.

INDASI LIFESCIENCE PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AVIV FARMACEUTICA SA — $40.3K across 2 shipments (32.8% of this supplier's total exports)

• AVIV FARMACEUTICA S.ACALZADA — $33.0K across 2 shipments (26.9% of this supplier's total exports)

• AVIV FARMACEUTICA S.ACALZADA — $25.0K across 1 shipments (20.4% of this supplier's total exports)

• AVIV FARMACEUTICA S.ACALZADA — $24.5K across 1 shipments (19.9% of this supplier's total exports)

Key Insight: INDASI LIFESCIENCE PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $20.5K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Fosfomycin imports from India, with a total trade value of $9.9M across 123 shipments — representing a 76.9% share of all Fosfomycin exports. The average shipment value of $80.6K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Fosfomycin importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 81.2% ($8.1M) of this market's total imports.

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $8.1M (81.2% of United States's total)

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.5M (15.6% of United States's total)

• AMNEAL PHARMACEUTICALS, LLC (KY) — $215.4K (2.2% of United States's total)

Key Insight: United States's per-shipment average of $80.6K (208% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Fosfomycin imports from India.

Primary Market

Secondary Market

2Germany

Germany ranks as the second-largest destination for Fosfomycin imports from India, with a total trade value of $1.2M across 0 shipments — representing a 9.3% share of all Fosfomycin exports. The average shipment value of $1.2M is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Germany's per-shipment average of $1.2M (4499% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Fosfomycin imports from India.

Primary Market

Secondary Market

3Guatemala

Guatemala ranks as the third-largest destination for Fosfomycin imports from India, with a total trade value of $505.6K across 9 shipments — representing a 3.9% share of all Fosfomycin exports. The average shipment value of $56.2K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Fosfomycin importers in Guatemala: AVIV FARMACEUTICA S.A is the largest buyer, accounting for 48.1% ($243.1K) of this market's total imports.

• AVIV FARMACEUTICA S.A — $243.1K (48.1% of Guatemala's total)

• AVIV FARMACEUTICA S.ACALZADA — $25.0K (4.9% of Guatemala's total)

Key Insight: Guatemala's per-shipment average of $56.2K (115% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Guatemala is a key market for Fosfomycin imports from India.

Primary Market

Secondary Market

4Tunisia

Tunisia ranks as the fourth-largest destination for Fosfomycin imports from India, with a total trade value of $497.4K across 0 shipments — representing a 3.9% share of all Fosfomycin exports. The average shipment value of $497.4K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Tunisia's per-shipment average of $497.4K (1799% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tunisia is a key market for Fosfomycin imports from India.

Primary Market

Secondary Market

5Uzbekistan

Uzbekistan ranks as the fifth-largest destination for Fosfomycin imports from India, with a total trade value of $172.6K across 6 shipments — representing a 1.3% share of all Fosfomycin exports. The average shipment value of $28.8K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Fosfomycin importers in Uzbekistan: MCHZH KONARK PHARM is the largest buyer, accounting for 100.0% ($172.6K) of this market's total imports.

• MCHZH KONARK PHARM — $172.6K (100.0% of Uzbekistan's total)

Key Insight: Uzbekistan's per-shipment average of $28.8K (10% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Uzbekistan is a key market for Fosfomycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fosfomycin.
2.Flow Mapping: 73 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 492 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 46 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

492 Verified Shipments

73 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Fosfomycin

Fosfomycin

Who Supplies Fosfomycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Fosfomycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Fosfomycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1CIPLA LIMITED

2SWISS PARENTERALS LIMITED

3AMNEAL PHARMACEUTICALS PRIVATE LIMITED

4AVANTIKA MEDEX PRIVATE LIMITED

5SRS PHARMACEUTICALS PRIVATE LIMITED

6INDASI LIFESCIENCE PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Fosfomycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Fosfomycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Germany

3Guatemala

4Tunisia

5Uzbekistan

People Also Ask — Fosfomycin Supplier & Trade Network

Fosfomycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology